0001209191-17-020952.txt : 20170315
0001209191-17-020952.hdr.sgml : 20170315
20170315203748
ACCESSION NUMBER: 0001209191-17-020952
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170314
FILED AS OF DATE: 20170315
DATE AS OF CHANGE: 20170315
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novack David F
CENTRAL INDEX KEY: 0001573072
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 17692700
MAIL ADDRESS:
STREET 1: 39 YORKSHIRE DR
CITY: OAKLAND
STATE: CA
ZIP: 94618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-14
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001573072
Novack David F
C/O DYNAVAX TECHNOLOGIES
2929 SEVENTH STREET, SUITE 100
BERKELEY
CA
94710
0
1
0
0
Senior Vice President
Common Stock
2017-03-14
4
M
0
20000
0.00
A
22121
D
Common Stock
2017-03-14
4
F
0
7947
5.75
D
14174
D
Restricted Stock Unit
2017-03-14
4
M
0
20000
D
2024-03-13
Common Stock
20000
0
D
Each restricted stock unit represents a right to receive one share of common stock.
The reporting person is reporting the withholding by Dynavax Technologies Corporation of 7,947 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 14, 2017.
Represents the conversion upon vesting of restricted stock awards into common stock. The reporting person was granted 20,000 restricted stock units on March 11, 2014 which vested on March 14, 2017. Such restricted stock units were previously reported in Table I on a Form 4 filed with the Securities and Exchange Commission on March 13, 2014.
David Novack, by /s/ Michael Ostrach, Attorney-in Fact
2017-03-15